Personal information

Cell Therapy; Regenerative Medicine; Stem Cells

Biography

She is the R&D director of the Cell Factory, a unit dedicated to basic research and to GMP cell therapy protocols in the field of stem cells and since 2017 she is the active Qualified Person of the GMP facility, Cell Factory, in Milano.
She coordinates and supervises all the experimental work, supervises the writing, editing and publication of scientific papers and is responsible for intra- and extra-departmental scientific activities at the Cell Factory. She is a reviewer for several international scientific journals and she is principal investigator in a number of national and international research programs and consortia related to basic and clinical research on stem cells. In addition, she has been often invited by private and public associations, charities and European governments in order to spread her knowledge about stem cells giving her the possibility to disseminate the interesting results obtained in this field. In 1992 Lorenza Lazzari founded the Milano Cord Blood Bank, one of the largest public cord blood banks in Europe. Her main field includes hematopoietic and non-hematopoietic stem cells from several sources for research and clinical applications. In the last years her research group has been pioneer in investigating the role played by exosomes and extracellular vesicles in regenerative medicine.
Currently, her most important research target is to understand the mechanisms underlying the therapeutic effects of stem cells. For this reason in her research lab new experimental approaches are going on, trying to connect extracellular vesicles, mitochondria, metabolism and stem cells fate. Since 2016 she has become a reference in Italy for the human pancreatic organoid production https://lsfm4life.eu increasing more and more her knowledge in the field of organoids as a model of disease and as an innovative regenerative medicine approach.

Activities

Employment (11)

French National Centre for Scientific Research: Paris, FR

2022 to present | Member of the Scientific and Technological Committee, French Priority Equipment and Research Programme (PEPR) on Biotherapy and Bioproduction of Innovative Technologies (BBIT)
Employment
Source: Self-asserted source
Lorenza Lazzari

Finnish Red Cross: Helsinki, FI

2018 to present | Member of the Scientific Advisory Board
Employment
Source: Self-asserted source
Lorenza Lazzari

Cell Factory, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano: Milano, Milano, IT

2017 to present | Qualified Person - GMP facilty
Employment
Source: Self-asserted source
Lorenza Lazzari

FIRST - Forum of Italian Researchers on Mesenchymal and Stromal Stem Cells: Milano, IT

2009 to present | President
Employment
Source: Self-asserted source
Lorenza Lazzari

Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico: Milano, IT

2005 to present | Technical Director/Qualified Person of GMP units authorized for the production of Medicinal Specialties by the Ministry of Health (Cell Factory GMP)
Employment
Source: Self-asserted source
Lorenza Lazzari

National Board of Biologists: Roma, IT

1995 to present | Member
Employment
Source: Self-asserted source
Lorenza Lazzari

Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico: Milano, IT

1992 to present | R&D Director (Laboratory of Regenerative Medicine - Cell Factory)
Employment
Source: Self-asserted source
Lorenza Lazzari

Stem Cells Journal: Durham, NC, US

2008 to 2019 | Lead reviewer (Editorial Board)
Employment
Source: Self-asserted source
Lorenza Lazzari

Lazzari Srl: Lecco, IT

2006 to 2019 | Partner and adviser on the board of directors
Employment
Source: Self-asserted source
Lorenza Lazzari

Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico: Milano, IT

2012 to 2017 | Member (Scientific Board)
Employment
Source: Self-asserted source
Lorenza Lazzari

Fondazione IRCCS - Ca' Granda Ospedale Maggiore: Milano, IT

1992 to 1995 | Co-founder (Milano Cord Blood Bank)
Employment
Source: Self-asserted source
Lorenza Lazzari

Education and qualifications (4)

Liceo Classico A Manzoni: Lecco, IT

High school degree
Education
Source: Self-asserted source
Lorenza Lazzari

Istituto Maria Ausiliatrice: Lecco, IT

First grade secondary school
Education
Source: Self-asserted source
Lorenza Lazzari

Università degli Studi di Milano: Milano, Lombardia, IT

1997 | Master degree in Biology (Pharmacology and Tossicology Institute )
Education
Source: Self-asserted source
Lorenza Lazzari

Università degli Studi di Milano: Milano, Lombardia, IT

1992 (Specialty in Experimental Endocrinology )
Education
Source: Self-asserted source
Lorenza Lazzari

Professional activities (5)

FIRST, Forum of Italian Researchers on Mesenchymal and Stromal Stem Cells : Milano, IT

2009 to present | President
Service
Source: Self-asserted source
Lorenza Lazzari

Ministero dell'Istruzione dell'Università e della Ricerca: Roma, Lazio, IT

2020-11-02 | National scientific qualification for Full Professor – sector 05/B2 (Comparitive anatomy and cytology, BIO/06)
Distinction
Source: Self-asserted source
Lorenza Lazzari

Ministero dell'Istruzione dell'Università e della Ricerca: Roma, Lazio, IT

2020-11-02 | National scientific qualification for Full Professor – sector 05/F1 (Applied biology, BIO/13)
Distinction
Source: Self-asserted source
Lorenza Lazzari

Ministero dell'Istruzione dell'Università e della Ricerca: Roma, Lazio, IT

2020-11-02 | National scientific qualification for Full Professor – sector 05/H2 (Istology, BIO/17)
Distinction
Source: Self-asserted source
Lorenza Lazzari

Ministero dell'Istruzione dell'Università e della Ricerca: Roma, Lazio, IT

2020-11-02 | National scientific qualification for Full Professor – sector 06/N1 (Science of Health Professions, MED/50)
Distinction
Source: Self-asserted source
Lorenza Lazzari

Funding (5)

Anti-inflammatory miRNA nanoshuttles as therapeutic strategy for stroke” (Proposal acronym: NANO4STROKE)

2021 to present | Grant
Euronanomed 2021 (Europe, BE)
Source: Self-asserted source
Lorenza Lazzari

A network for cell and gene therapies for devastating diseases” (Proposal acronym: PLAGENCELL)

2020 to present | Grant
Fondazione Regionale per la Ricerca Biomedica FRRB (Milano, IT)
Source: Self-asserted source
Lorenza Lazzari

Authorisation of preparation processes in blood and tissues and cells” (Proposal acronym: GAPP)

2019 to present | Grant
European Commission (Bruxelles, LU)
Source: Self-asserted source
Lorenza Lazzari

Autologous mesenchymal stem/stromal cells for the treatment of workers affected by chronic low back pain due to multilevel intervertebral disc degeneration: a phase iib randomized clinical trial (ACTIVE)

2019 to present | Grant
INAIL (Rome, IT)
Source: Self-asserted source
Lorenza Lazzari

Production and characterization of endocrine cells derived from human pancreas organoids for cell-based therapy of type 1 diabetes” (Proposal acronym: LSFM4LIFE)

2016 to present | Grant
European Commission (Bruxelles, BE)
GRANT_NUMBER:

Contract n° CE 668350

Source: Self-asserted source
Lorenza Lazzari